MELISSA BAUGHCUM: Open Payments
NPI 1013276518 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,529 in 208 payments from 24 companies in 2025. Trend: 2023 $3,200 · 2024 $5,231 · 2025 $10,529
Food & beverage: $4,908Speaker / faculty: $4,125Travel & lodging: $771Honoraria: $640Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 25 | $5,270 |
| ABBVIE INC. | 41 | $883 |
| Ipsen Biopharmaceuticals, Inc | 8 | $778 |
| Phathom Pharmaceuticals, Inc. | 7 | $776 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $626 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $296 |
| Janssen Biotech, Inc. | 10 | $293 |
| Regeneron Healthcare Solutions, Inc. | 9 | $232 |
| GENZYME CORPORATION | 9 | $205 |
| PFIZER INC. | 14 | $184 |
Products named: REZDIFFRA, VOQUEZNA, XIFAXAN, DUPIXENT, TREMFYA, ENTYVIO, RINVOQ, SKYRIZI.
Industry payments across GA — which companies pay providers there.
